Quantinno Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.94M Buy
3,841
+1,299
+51% +$687K ﹤0.01% 2217
2026
Q2
$1.36M Buy
2,542
+452
+22% +$232K ﹤0.01% 2310
2026
Q1
$1.09M Buy
2,090
+1,726
+474% +$825K ﹤0.01% 2083
2025
Q4
$212K Buy
+364
New +$186K ﹤0.01% 3029
2025
Q2
– Sell
-2,644
Closed -$876K – 2611
2025
Q1
$876K Buy
+2,644
New +$869K 0.01% 1195

Other funds holding MDGL

Quantinno Capital Management's MDGL Position: Q3 2026 in Review

Quantinno Capital Management increased its Madrigal Pharmaceuticals (MDGL) stake by 51% in Q3 2026, buying an estimated $687K and bringing the position to 3,841 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

Quantinno Capital Management first reported a position in MDGL in Q1 2025 and has held it in 5 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Quantinno Capital Management held 3,841 shares of Madrigal Pharmaceuticals worth $1.94M as of Q3 2026.
  • Quantinno Capital Management bought 1,299 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $687K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2217 holding.
  • Quantinno Capital Management first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.